Tech Tour Growth Health is one of Europe's most established gatherings at the intersection of healthcare innovation and investment –…
Volv Global is pleased to be participating in the Life Sciences Innovation & Investment Corridor between Lausanne & London, hosted…
The idea that an AI system could detect a disease that appears nowhere in a patient's medical record sounds like…
The ISPOR International Annual Conference 2026 brings together global leaders in health economics and outcomes research to explore the future…
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Inflammatory Bowel Disease (IBD) management has evolved significantly with advanced therapies…
Introduction Advocacy plays a critical role in accelerating progress in rare diseases. As technology advances, collaboration between patient communities, researchers,…
As our commemoration of Rare Disease Day 2026, we are pleased to present a guest article by Jessica Lynn at…
By Léon Van Wouwe, Clinical Innovation Director, Volv Global Introduction Earlier cancer detection remains one of the most powerful opportunities…
Finding the Patients We're Missing Rare diseases often remain undiagnosed for years, leaving patients without timely treatment and care. Despite…
Introduction Volv Global participation in Faces of Industrial Research 2026 reflects its commitment to connecting scientific innovation with real-world healthcare…